All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live
Think like Sam Zell when investing: Buy hard assets below replacement cost when future capacity will be needed. You'll acquire at a discount and sell at a premium when the market wakes up. This works across real estate, power infrastructure, and any scarce resource where demand is growing faster tha
1h 7mKey Takeaway
Think like Sam Zell when investing: Buy hard assets below replacement cost when future capacity will be needed. You'll acquire at a discount and sell at a premium when the market wakes up. This works across real estate, power infrastructure, and any scarce resource where demand is growing faster than supply can respond.
Episode Overview
Investment managers present their best ideas at an Ira Sohn Foundation event, pitching opportunities in gaming (MGM), power infrastructure (Talon Energy), and biotech (Actis Oncology). The presentations reveal systematic approaches to finding undervalued assets with catalysts ahead, from casino licensing in Asia to nuclear power for AI data centers.
Key Insights
Hidden Assets Create Asymmetric Returns
MGM trades at $48 but owns underappreciated assets worth over $100: a casino license in Osaka, Japan opening in 2030 (worth ~$50/share), Vegas properties ($60), and optionality on Dubai gambling legalization ($40-50). Barry Diller's aggressive buying (26% ownership) and his $48 bid signal he sees the value others are missing.
Power Demand Cycles Follow Technological Breakthroughs
Throughout history, power demand spikes when transformative technologies emerge (appliances, air conditioning), then normalizes, then enters an efficiency phase. We're now entering a new spike driven by AI and data centers. The PJM region alone needs 106 gigawatts of new power in 10 years—equivalent to Japan's entire consumption.
Data Centers Are the New Refineries
A data center functions exactly like an oil refinery: electricity goes in, and refined output (intelligence, tokens, photons) comes out. Both are capital-intensive ($50 billion per gigawatt), require massive energy inputs, and create value by transforming raw resources into usable products.
Replacement Cost Provides a Valuation Floor
Talon Energy can be bought at $25 billion enterprise value while replacement cost is $45 billion—a potential double just to reach parity. When scarce assets trade below what it costs to build new capacity, and demand is growing, the market will eventually reprice them at a premium.
De-risk Biotech Bets Through Margin of Safety
Actis Oncology represents a value-oriented approach to biotech: target proven receptors (nectin-4, B7H3), verify engagement through imaging early, maintain 3+ years of cash runway, and choose modalities (radiopharmaceuticals) with real moats that generics and China can't easily replicate.
Notable Quotes
"If you can buy an asset, a hard asset at below replacement cost for an asset that's going to be needed in the future where we're going to need to build new capacity of that asset. Then you buy that asset at the discount to replacement cost. You hold it and you sell it at a big premium to replacement cost when the market wakes up."
"We do not need AI demand to keep the power markets incredibly tight for the next 20 years. AI demand just turbocharges. That's all it does. And it creates shortages."
"If you believe that artificial intelligence is going to be responsible for scientific breakthroughs, you either have it or you don't have the scientific breakthroughs. If you believe that artificial intelligence is going to drive robotics, you either have it or you don't have that productivity from the robots. If you believe that artificial intelligence is going to be helpful for national security and military affairs, then you either have it or you're dead."
"I think this company is now in play. I don't know how it's all going to play out, but if you own shares, don't tender them. And the riskreward is incredible right now because, you know, I'm telling you, I think the stock could be easily worth over 100, could be worth 150."
"Generally speaking, investing in biotech companies is a horrible idea sandwiched somewhere between movies, wineries, and spaxs. In fact, our sector often feels a lot more like a casino than an actual financial market."
Action Items
-
1
Apply Sam Zell's Replacement Cost Framework
Before making any investment in hard assets (real estate, infrastructure, commodities), calculate the replacement cost. If you can buy below replacement cost and future demand will require new capacity, you have downside protection and asymmetric upside when the market reprices the asset.
-
2
Look for Hidden Assets in Public Companies
Study companies where management barely mentions valuable optionality in presentations—these are often mispriced by the market. Examples include future licensing opportunities (MGM's Osaka casino), unrealized real estate value, or technological platforms that could be applied beyond initial use cases.
-
3
Follow Smart Money Aggressively Buying
When sophisticated investors like Barry Diller accumulate 26% of a company and make public bids, dig deeper. They likely see value the market is missing. Track 13-F filings and insider buying to identify where experienced investors are placing concentrated bets.
-
4
Invest in Scarce Resources Before Demand Materializes
Position yourself in constrained resources (power generation capacity, rare earth elements, specialized manufacturing) before the market fully prices in upcoming demand. The PJM region needing 106 gigawatts exemplifies how infrastructure takes years to build while demand can spike quickly.